Whiteoak Capital Pharma And Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 31-07-2026
NAV ₹16.55(R) +0.41% ₹17.28(D) +0.42%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 17.02% -% -% -% -%
Direct 19.04% -% -% -% -%
Nifty Pharma TRI 17.24% 21.8% 13.75% 19.6% 9.31%
SIP (XIRR) Regular 35.11% -% -% -% -%
Direct 37.37% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 486 Cr

NAV Date: 31-07-2026

Scheme Name NAV Rupee Change Percent Change
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 16.55
0.0700
0.4100%
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth 17.28
0.0700
0.4200%

Review Date: 31-07-2026


Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 3.77 4.98
3.61
1.37 | 5.75 9 | 17 Good
3M Return % 16.42 14.39
14.20
9.15 | 17.37 4 | 17 Very Good
6M Return % 27.49 23.79
23.46
17.44 | 30.32 4 | 17 Very Good
1Y Return % 17.02 17.24
12.94
6.28 | 19.01 4 | 16 Very Good
1Y SIP Return % 35.11
28.89
6.42 | 39.86 5 | 16 Good
Return data last Updated On : July 31, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 3.92 4.98 3.72 1.41 | 5.85 9 | 17 Good
3M Return % 16.93 14.39 14.59 9.37 | 17.82 4 | 17 Very Good
6M Return % 28.56 23.79 24.29 17.94 | 31.33 4 | 17 Very Good
1Y Return % 19.04 17.24 14.49 7.17 | 20.57 4 | 16 Very Good
1Y SIP Return % 37.37 30.60 7.73 | 42.03 4 | 16 Very Good
Return data last Updated On : July 31, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Whiteoak Capital Pharma And Healthcare Fund NAV Regular Growth Whiteoak Capital Pharma And Healthcare Fund NAV Direct Growth
31-07-2026 16.554 17.284
30-07-2026 16.487 17.212
29-07-2026 16.529 17.256
28-07-2026 16.344 17.062
27-07-2026 16.374 17.092
24-07-2026 16.079 16.781
23-07-2026 16.08 16.782
22-07-2026 16.18 16.885
21-07-2026 16.364 17.077
20-07-2026 16.304 17.013
17-07-2026 16.102 16.801
16-07-2026 16.255 16.959
15-07-2026 16.293 16.998
14-07-2026 16.222 16.923
13-07-2026 16.162 16.86
10-07-2026 16.175 16.872
09-07-2026 16.125 16.819
08-07-2026 15.883 16.565
07-07-2026 16.007 16.694
06-07-2026 16.145 16.836
03-07-2026 16.209 16.901
02-07-2026 16.054 16.739
01-07-2026 15.904 16.582
30-06-2026 15.953 16.632

Fund Launch Date: 06/Feb/2024
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Description: An open ended equity scheme investing in Pharma and Healthcare sector
Fund Benchmark: BSE Healthcare Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.